Search

Professor Mark Middleton

Medical oncology

  • Fee assured
Overview
COVID-19

You'll need to contact this healthcare professional to check their availability

Specialises in

  • Skin
  • Upper GI

Offers

  • Home chemotherapy

About me

Professor Middleton trained at the Universities of Cambridge and Oxford, qualifying in 1991. He trained in Medical Oncology at the Christie Hospital and Paterson Institute in Manchester. He has an international reputation for the care of patients with melanoma, contributing to numerous clinical trials and contributing to the development of new medicines such as vemurafenib, ipilimumab and nivolumab. Prof Middleton is based at Oxford University Hospitals NHS Trust where he also works on the Early Phase Clinical Trials Unit

Areas of interest

Treatment of melanoma and upper GI cancer, including with targeted agents, chemotherapy and immunotherapy. Cancer drug development and experimental therapeutics.

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (5-50)

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (1-5)

  • AA841

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 0-7 days - (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.